Related content

XELIRI compared with FOLFIRI as a secondline treatment in patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1864-1872

Spandidos Publications

Access to resources Recommend Favorite

Oral multikinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer

By Cremolini Chiara   Schirripa Marta   Loupakis Fotios   Falcone Alfredo  

Colorectal Cancer, Vol. 2, Iss. 5, 2013-10 ,pp. : 411-417

Future Medicine

Access to resources Recommend Favorite

A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients

By Ogawa Kohei   Ueno Takao   Kato Ken   Nishitani Hitoshi   Akiyoshi Kohei   Iwasa Satoru   Nakajima Takako   Hamaguchi Tetsuya   Yamada Yasuhide   Hosokawa Ayumu   Sugiyama Toshiro   Shimada Yasuhiro  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1020-1024

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco   Fornarini Giuseppe  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

Immunotherapy in the Initial Treatment of Newly Diagnosed Cancer Patients: Utilization Trend and Cost Projections for Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Metastatic Colorectal Cancer

By Shih Ya-Chen Tina   Elting Linda S.   Pavluck Alexandre L.   Stewart Andrew   Halpern Michael T.  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 46-53

Informa Healthcare

Access to resources Recommend Favorite